Science Explorer Interactive view Map
Company · Waltham · United States

NKT Therapeutics (United States)

Research works
90
▼ 22% vs 2013–17
Citations
4.8k
52.6 per fractional work
Top-10% rate
16.4%
record average 16.5%
Open access
45%
world 28%

Not ranked overall: NKT Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.83× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 17.09× its world share, 5 worksImmunology and Micro…Neuroscience: 1.26× its world share, 1 worksNeuroscienceChemistry: 0.59× its world share, 0 worksChemistryComputer Science: 0.13× its world share, 0 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringEnvironmental Science: 0.11× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.10× its world share, 0 worksMaterials ScienceMedicine: 2.41× its world share, 14 worksMedicineNursing: 0.57× its world share, 0 worksNursingworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 17.1×. Every wedge is a field page.

Which keywords describe research at NKT Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Regulatory T Cells, Immune System, TGF-ß, Cancer Therapy, IL-17 and TH17 Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 32 words, with their numbers
  1. Cancer4▲ 10×14 topics
  2. Inflammation4▲ 6.8×15 topics
  3. Epidemiology3▲ 2.2×7 topics
  4. Regulatory T Cells3▲ 75×2 topics
  5. Immune System2▲ 28×2 topics
  6. Treatment2▲ 5.4×3 topics
  7. TGF-ß2▲ 42×3 topics
  8. Cancer Therapy2▲ 11×9 topics
  9. IL-172▲ 179×1 topic
  10. Immune Dysregulation2▲ 76×2 topics
  11. TH17 Cells2▲ 179×1 topic
  12. Autoantibodies2▲ 24×3 topics
  13. Metabolism2▲ 11×6 topics
  14. Glycosylation2▲ 48×2 topics
  15. Management2▲ 6.9×5 topics
  16. Monoclonal Antibodies2▲ 58×2 topics
  17. Allergic Diseases2▲ 88×1 topic
  18. Angiogenesis2▲ 16×7 topics
  19. Asthma2▲ 53×1 topic
  20. Transcriptional Regulation2▲ 30×4 topics
  21. Tumor Microenvironment2▲ 12×6 topics
  22. Fc Receptors1▲ 88×1 topic
  23. Therapeutic Antibodies1▲ 69×1 topic
  24. Filaggrin1▲ 93×1 topic
  25. Skin Microbiome1▲ 93×1 topic
  26. Diagnosis1▲ 4.3×3 topics
  27. Signaling1▲ 71×2 topics
  28. Chemotherapy1▲ 5.2×4 topics
  29. Immune Response1▲ 6.7×5 topics
  30. Obesity1▲ 4.5×2 topics
  31. Quality of Life1▲ 2.3×3 topics
  32. Therapy1▲ 17×2 topics

Which research topics does NKT Therapeutics (United States) publish most on?

By volume in 2022–2025: Psoriasis: Treatment and Pathogenesis, Asthma and respiratory diseases, Monoclonal and Polyclonal Antibodies Research and Dermatology and Skin Diseases.

  1. 1 Psoriasis: Treatment and Pathogenesis Immunology 2 works
  2. 2 Asthma and respiratory diseases Physiology 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Dermatology and Skin Diseases Dermatology 1 works
  5. 5 Fibroblast Growth Factor Research Molecular Biology 1 works
  6. 6 IL-33, ST2, and ILC Pathways Immunology 1 works
  7. 7 Urticaria and Related Conditions Rheumatology 1 works
  8. 8 Protein Degradation and Inhibitors Molecular Biology 1 works
  9. 9 Galectins and Cancer Biology Immunology 1 works
  10. 10 CRISPR and Genetic Engineering Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.7%not open55.3%

World: 28% of research is openly available.

with international co-authors26.9%domestic only73.1%

World: 19% is written across borders.

How has NKT Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 22% lower than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Waltham

All research institutions in Waltham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.